LeonaBio, Inc. Settlement Liabilities, Current
LeonaBio, Inc. (LONA) had Settlement Liabilities, Current of $0 as of 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Notes
us-gaap:SettlementLiabilitiesCurrent · last filed 2026-03-31
- 2025-12-31: Settlement Liabilities, Current $0.00.
- 2024-12-31: Settlement Liabilities, Current $4.13M.
- 2024-09-30: Settlement Liabilities, Current $4.13M.
| Period end | Settlement Liabilities, Current |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-31 |
| 2024-12-31 | $4.13M 10-K · filed 2026-03-31 |
| 2024-09-30 | $4.13M 10-Q · filed 2024-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |